We are live on ! Find out more
CKPT

Checkpoint Therapeutics
CKPT

Delisted

CKPT was delisted on the 29th of May, 2025.

Back to rankings

62 hedge funds and large institutions have $10.3M invested in Checkpoint Therapeutics in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more call options, than puts

Call options by funds: $480K | Put options by funds: $137K

0.49% less ownership

Funds ownership: 1.68% → 1.19% (-0.49%)

7% less funds holding

Funds holding: 67 → 62 (-5)

27% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 11

35% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 17

55% less capital invested

Capital invested by funds: $22.8M → $10.3M (-$12.5M)

Holders
62
Holders Change
-5
Holders Change %
-7.46%
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
11
Reduced
17
Closed
11
Calls
$480K
Puts
$137K
Net Calls
+$343K
Net Calls Change
+$233K

Top Buyers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
+$83K
2
VF
Virtu Financial
New York
+$65.2K
3
RJFSA
Raymond James Financial Services Advisors
Florida
+$56.1K
4
JSMC
Jess S. Morgan & Co
California
+$55.8K
5
BlackRock
BlackRock
New York
+$47K

Top Sellers

Rank Fund Capital Flow
1
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$1.96M
2
Norges Bank
Norges Bank
Norway
-$475K
3
Millennium Management
Millennium Management
New York
-$386K
4
Two Sigma Investments
Two Sigma Investments
New York
-$336K
5
Goldman Sachs
Goldman Sachs
New York
-$292K
Name Holding Trade Value Shares
Change 		Change in
Stake
SWM
51
Spire Wealth Management
Virginia
$5K – – –
LC
52
Lindbrook Capital
California
$3K – – –
TFGT
53
TS Financial Group (TSFG)
Illinois
$3K – – –
TCWM
54
Total Clarity Wealth Management
Illinois
$3K +$3.93K +300 New
TFS
55
TrustCore Financial Services
Tennessee
$2K – – –
ED
56
Exane Derivatives
France
$1.66K -$35.7K -2,724 -94%
BNP Paribas Financial Markets
57
BNP Paribas Financial Markets
France
$1.01K – – –
CAPTRUST Financial Advisors
58
CAPTRUST Financial Advisors
North Carolina
$1K – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
59
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$1.96M -110,710 Closed
Norges Bank
60
Norges Bank
Norway
– -$475K -26,850 Closed
Goldman Sachs
61
Goldman Sachs
New York
– -$292K -16,521 Closed
CSS
62
Cubist Systematic Strategies
Connecticut
– -$166K -9,381 Closed
AA
63
ALPS Advisors
Colorado
– -$152K -8,609 Closed
TI
64
Telemetry Investments
New York
– -$80K -4,500 Closed
Qube Research & Technologies (QRT)
65
Qube Research & Technologies (QRT)
United Kingdom
– -$74K -4,181 Closed
ECM
66
ExodusPoint Capital Management
New York
– -$49K -2,755 Closed
CI
67
Cordant Inc
Oregon
– -$19K -1,082 Closed
Citigroup
68
Citigroup
New York
– -$7K -370 Closed
Wells Fargo
69
Wells Fargo
California
– -$1.81K -138 -75%
MAM
70
Meeder Asset Management
Ohio
– -$2K -96 Closed
Fidelity Investments
71
Fidelity Investments
Massachusetts
– +$131 +10 New
1 2
3

CKPT Hedge Fund Activity: Q2 2022 in Review

62 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q2 2022, worth a combined $10.3M — down 55% from $22.8M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of CKPT and 8 opened new positions — a net loss of 3 holders — while 17 trimmed existing stakes and 11 added.

The largest buyer was GSA Capital Partners, opening a new position worth an estimated $83K. The largest seller was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, exiting entirely with an estimated $1.96M sold.

  • 62 institutional investors held Checkpoint Therapeutics (CKPT) as of Q2 2022, down from 67 in Q1 2022.
  • Funds reported $10.3M of Checkpoint Therapeutics stock for Q2 2022, down 55% quarter-over-quarter.
  • 8 funds opened new Checkpoint Therapeutics positions in Q2 2022 and 11 closed out, a net change of -3 holders.
  • The largest Checkpoint Therapeutics buyer in Q2 2022 was GSA Capital Partners, an estimated $83K added.
  • The largest Checkpoint Therapeutics seller in Q2 2022 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $1.96M sold.

Based on aggregated 13F filings for Q2 2022.